Beta Bionics (BBNX) Long-Term Investments (2025 - 2026)
Beta Bionics' (BBNX) quarterly Long-Term Investments came in at $39.9 million in Q1 2026, down 37.71% year-on-year from $64.0 million in Q1 2025, and down 12.25% quarter-over-quarter from $45.4 million in Q4 2025.
Beta Bionics (BBNX) Long-Term Investments (2025 - 2026) Analysis & Trends
Beta Bionics has disclosed Long-Term Investments across 2 years of filings, most recently posting $39.9 million for Q1 2026.
- Long-Term Investments for Q1 2026 came in at $39.9 million, down 37.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $39.9 million (down 37.71% YoY), and the FY2025 annual result was $45.4 million, changed N/A from the prior year.
- Long-Term Investments came in at $39.9 million for Q1 2026 at Beta Bionics, down from $45.4 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $64.0 million in Q1 2025 to a low of $31.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 166.25 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Beta Bionics | 617.66 Mn | 587.36 Mn | 16.44 Mn | 39.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.87 Mn |
| Dec 31, 2025 | 45.43 Mn |
| Sep 30, 2025 | 45.33 Mn |
| Jun 30, 2025 | 31.15 Mn |
| Mar 31, 2025 | 64.00 Mn |